CSL Behring Australia
The Senior Scientist, Quantitative Modeling & PK supports non-clinical drug development by applying quantitative modeling approaches to inform key decisions from candidate selection through first-in-human dose prediction. The role involves collaborating with cross-functional teams to design studies, integrate datasets, and develop predictive models to translate quantitative insights into actionable recommendations. This position requires a strong understanding of pharmacokinetics, pharmacology, and non-clinical development to maximize decision-making value and reduce development risk.
CSL Behring Australia is a biopharmaceutical leader driven by its promise to save and improve lives. We manufacture remedies for rare and serious conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CSL Behring Australia.
CSL Behring Australia didn’t post a salary, so this is our estimate from similar listings.
Director of Clinical Pharmacology Modeling and Simulation
GSK plc
Associate Director Preclinical & Translational PK/PD
Regeneron Pharmaceuticals
Postdoctoral Research Fellow in Quantitative Pharmacology and Pharmacometrics
MSD
Principal Scientist II/Senior Principal Scientist, Modeling & Simulation (Dual Level Posting)
Novartis
Quantitative Clinical Pharmacologist
Eli Lilly and Company
Director, Infectious Diseases and Vaccines, Quantitative Pharmacology and Pharmacometrics
Merck & Co., Inc.